Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms.
Burrello J, Gallone G, Burrello A, Jahier Pagliari D, Ploumen EH, Iannaccone M, De Luca L, Zocca P, Patti G, Cerrato E, Wojakowski W, Venuti G, De Filippo O, Mattesini A, Ryan N, Helft G, Muscoli S, Kan J, Sheiban I, Parma R, Trabattoni D, Giammaria M, Truffa A, Piroli F, Imori Y, Cortese B, Omedè P, Conrotto F, Chen SL, Escaned J, Buiten RA, Von Birgelen C, Mulatero P, De Ferrari GM, Monticone S, D'Ascenzo F. Burrello J, et al. Among authors: von birgelen c. J Pers Med. 2022 Jun 17;12(6):990. doi: 10.3390/jpm12060990. J Pers Med. 2022. PMID: 35743777 Free PMC article.
Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions.
Tu S, Echavarria-Pinto M, von Birgelen C, Holm NR, Pyxaras SA, Kumsars I, Lam MK, Valkenburg I, Toth GG, Li Y, Escaned J, Wijns W, Reiber JH. Tu S, et al. Among authors: von birgelen c. JACC Cardiovasc Interv. 2015 Apr 20;8(4):564-74. doi: 10.1016/j.jcin.2014.12.232. Epub 2015 Mar 26. JACC Cardiovasc Interv. 2015. PMID: 25819180 Free article.
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.
Zocca P, van der Heijden LC, Kok MM, Löwik MM, Hartmann M, Stoel MG, Louwerenburg JW, de Man FHAF, Linssen GCM, Knottnerus IL, Doggen CJM, van Houwelingen KG, von Birgelen C. Zocca P, et al. Among authors: von birgelen c. EuroIntervention. 2017 Nov 20;13(10):1168-1176. doi: 10.4244/EIJ-D-17-00634. EuroIntervention. 2017. PMID: 29151439 Free article.
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
Kok MM, von Birgelen C, Sattar N, Zocca P, Löwik MM, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Kant GD, Doelman C, Tjon Joe Gin M, Stoel MG, van Houwelingen G, Linssen GCM, IJzerman MJ, Doggen CJM, van der Heijden LC. Kok MM, et al. Among authors: von birgelen c. EuroIntervention. 2018 Oct 12;14(9):e1049-e1056. doi: 10.4244/EIJ-D-17-01067. EuroIntervention. 2018. PMID: 29313817 Free article.
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
van der Heijden LC, Kok MM, Zocca P, Sen H, Löwik MM, Mariani S, de Man FHAF, Hartmann M, Stoel MG, van Houwelingen KG, Louwerenburg JHW, Linssen GCM, Doggen CJM, Grandjean JG, von Birgelen C. van der Heijden LC, et al. Among authors: von birgelen c. J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212. J Am Heart Assoc. 2018. PMID: 29382666 Free PMC article.
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
von Birgelen C, Kok MM, Sattar N, Zocca P, Doelman C, Kant GD, Löwik MM, van der Heijden LC, Sen H, van Houwelingen KG, Stoel MG, Louwerenburg JHW, Hartmann M, de Man FHAF, Linssen GCM, Doggen CJM, Tandjung K. von Birgelen C, et al. JACC Cardiovasc Interv. 2018 Mar 12;11(5):448-459. doi: 10.1016/j.jcin.2017.10.038. Epub 2018 Feb 14. JACC Cardiovasc Interv. 2018. PMID: 29454724 Free article. Clinical Trial.
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.
Kok MM, Zocca P, Buiten RA, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Stoel MG, van Houwelingen G, Linssen GCM, Doggen CJM, von Birgelen C. Kok MM, et al. Among authors: von birgelen c. EuroIntervention. 2018 Oct 20;14(8):915-923. doi: 10.4244/EIJ-D-18-00336. EuroIntervention. 2018. PMID: 29790480 Free article. Clinical Trial.
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Zocca P, Kok MM, van der Heijden LC, van Houwelingen KG, Hartmann M, de Man FHAF, Stoel MG, Louwerenburg JHW, Knottnerus IL, Linssen GCM, Doggen CJM, von Birgelen C. Zocca P, et al. Among authors: von birgelen c. Int J Cardiol. 2018 Oct 1;268:11-17. doi: 10.1016/j.ijcard.2018.03.116. Epub 2018 May 23. Int J Cardiol. 2018. PMID: 29801763 Free article. Clinical Trial.
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Zocca P, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C. Zocca P, et al. Among authors: von birgelen c. Cardiovasc Drugs Ther. 2018 Dec;32(6):567-576. doi: 10.1007/s10557-018-6823-9. Cardiovasc Drugs Ther. 2018. PMID: 30143879 Free PMC article. Clinical Trial.
381 results